Applied Therapeutics, Inc. Announces Pricing for $30 Million Common Stock and Warrant Public Offering
Applied therapyNEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates ag...